Skip to main content
Clinical Trials/NCT00307333
NCT00307333
Completed
Not Applicable

Impact of Heart Rate Characteristics Monitoring in Neonates

University of Virginia8 sites in 1 country3,003 target enrollmentAugust 2005
ConditionsSepsis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis
Sponsor
University of Virginia
Enrollment
3003
Locations
8
Primary Endpoint
Number of Ventilator-free Days
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Hypothesis: Fewer neonates managed using information from heart rate characteristics (HRC) will require intubation and mechanical ventilation as a result of sepsis and sepsis-like illness.

Infants will be randomly assigned to one of two groups. One group of infants will have the HRC index known to the physicians caring for them, and physicians will use the HRC index as they desire to aid in clinical management.

Infants in the other group will have the HRC index recorded, but this information will not be displayed to the physicians caring for the infants.

Detailed Description

Following randomization, infants will be managed as usual practice. The treating physicians of the HRC-display group will be able to utilize the HRC score to assist in the care of the infant. The physicians of the no-display group will provide care as per standard. Clinical symptoms will be treated according to the medical discretion of each physician. Cultures will be obtained and antibiotics administered as per the medical discretion of the physicians. Clinical, culture results, antibiotic administration, ventilator use, and outcome at 120 days data will be collected on the infants as well as their HRC score calculated by the HeRO heart rate characteristics monitor.

Registry
clinicaltrials.gov
Start Date
August 2005
End Date
May 2011
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Infants admitted to NICU
  • Birth weight \< 1500 grams
  • Gestational age \< or = 32 weeks
  • Informed consent obtained from parent

Exclusion Criteria

  • Evidence of sustained cardiac arrhythmia
  • Use of an electronic pacemaker

Outcomes

Primary Outcomes

Number of Ventilator-free Days

Time Frame: 120 days

Secondary Outcomes

  • Duration of Hospital Stay(120 days)
  • Mortality(120 days)
  • Days on Antibiotics(120 days)

Study Sites (8)

Loading locations...

Similar Trials